Clinical Trial: A Phase I Clinical Trial to Evaluate HECN30227 Injection in Healthy Subjects and Subjects With Chronic Hepatitis B

U.S., Aug. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07771140) titled 'A Phase I Clinical Trial to Evaluate HECN30227 Injection in Healthy Subjects and Subjects With Chronic Hepatitis B' on Aug. 06.

Brief Summary: To evaluate the safety, efficacy, pharmacokinetics and immunogenicity of single and multiple doses of HECN30227 Injection in healthy volunteers and patients with chronic hepatitis B

Study Start Date: Dec. 02, 2025

Study Type: INTERVENTIONAL

Condition: HBV Infection

Intervention: DRUG: HECN30227 injection(SAD)

single subcutaneous administrations

DRUG: Placebo(MAD)

0.9% Sodium Chloride Injection

DRUG: Placebo(SAD)

0.9% Sodium Chloride Injection

DRUG: HECN30227 injection (MAD)

multi...